Reviewing OptiNose (OPTN) and Editas Medicine (EDIT)StockNewsTimesIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex c… Continue reading
OncLiveHyperprogression Emerges in a Subset of Patients Treated With ImmunotherapyOncLiveThe extent of hyperprogressive disease (HPD) after immunotherapy treatment has not been fully characterized, but evidence continues to build that it may not be as … Continue reading
Edgy Labs (blog)Why CRISPR Might not WorkEdgy Labs (blog)According to a recent study, CRISPR-Cas 9, the revolutionary gene-editing technique, could be blocked by the immune system and thus might not work on all people. If the genome can be compared to … Continue reading
Manitoba Co-operatorMonsanto highlights research pipeline for canola, soybeansManitoba Co-operatorCRISPR is one that has made headlines, but new editing tools are being developed almost weekly, he said. Monsanto has been making deals with some of the d… Continue reading
Manitoba Co-operatorMonsanto highlights research pipeline for canola, soybeansManitoba Co-operatorCRISPR is one that has made headlines, but new editing tools are being developed almost weekly, he said. Monsanto has been making deals with some of the d… Continue reading
Genetic Engineering & Biotechnology NewsBioelectricity, New Peer Reviewed Journal AnnouncedGenetic Engineering & Biotechnology News“Bioelectricity is a hugely exciting and multifaceted topic,” says Associate Editor Michael Levin, Ph.D. “Prior discoveri… Continue reading
Global T-Cell Immunotherapy Market for Cancer & Pipeline AnalysisMarkets InsiderThe report provides an in-depth study on the current state of the T-Cell Immunotherapy industry. Recently, the USFDA approved two T-cell Immunotherapies for the treatme… Continue reading
MilTechGlobal T-Cell Immunotherapy Market for Cancer & Pipeline AnalysisPR Newswire (press release)The report provides an in-depth study on the current state of the T-Cell Immunotherapy industry. Recently, the USFDA approved two T-cell Immunotherap… Continue reading